首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Negative Regulation of Mitochondrial Antiviral Signaling Protein-Mediated Antiviral Signaling by the Mitochondrial Protein LRPPRC During Hepatitis C Virus Infection
【24h】

Negative Regulation of Mitochondrial Antiviral Signaling Protein-Mediated Antiviral Signaling by the Mitochondrial Protein LRPPRC During Hepatitis C Virus Infection

机译:线粒体抗病毒信号蛋白介导的线粒体蛋白LRPPR抗病毒信号在丙型肝炎病毒感染期间的负调节

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatitis C virus (HCV) is highly efficient in establishing a chronic infection, having evolved multiple strategies to suppress the host antiviral responses. The HCV nonstructural 5A (NS5A) protein, in addition to its role in viral replication and assembly, has long been known to hamper the interferon (IFN) response. However, the mechanism of this inhibitory activity of NS5A remains partly characterized. In a functional proteomic screening carried out in HCV replicon cells, we identified the mitochondrial protein LRPPRC as an NS5A binding factor. Notably, we found that downregulation of LRPPRC expression results in a significant inhibition of HCV infection, which is associated with an increased activation of the IFN response. Moreover, we showed that LRPPRC acts as a negative regulator of the mitochondrial-mediated antiviral immunity, by interacting with mitochondrial antiviral signaling protein (MAVS) and inhibiting its association with TRAF3 and TRAF6. Finally, we demonstrated that NS5A is able to interfere with MAVS activity in a LRPPRC-dependent manner. Conclusion: Overall, our results indicate that NS5A contributes to the inhibition of innate immune pathways during HCV infection by exploiting the ability of LRPPRC to inhibit MAVS-regulated antiviral signaling.
机译:丙型肝炎病毒(HCV)在建立慢性感染方面具有高效,具有进化的多种策略来抑制宿主抗病毒反应。除了在病毒复制和组装中的作用之外,HCV非结构5A(NS5A)蛋白已知已经众长,他们已经知道妨碍干扰素(IFN)反应。然而,NS5A的这种抑制活性的机制仍然是部分特征。在HCV复制子细胞中进行的功能蛋白质组学筛选中,我们将线粒体蛋白LRPPR鉴定为NS5A结合因子。值得注意的是,我们发现LRPPRC表达的下调导致HCV感染的显着抑制,这与IFN反应的增加相关。此外,我们认为LRPPR通过与线粒体抗病毒信号传导蛋白(MAV)相互作用并抑制其与TRAF3和TRAF6的关联来作为线粒体介导的抗病毒免疫的负调节剂。最后,我们证明NS5A能够以LRPPRC相关的方式干扰MAVS活动。结论:总体而言,我们的结果表明,NS5A通过利用LRPPRC抑制Mavs调节的抗病毒信号传导的能力,有助于在HCV感染期间抑制先天免疫途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号